C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2004
12/02/2004	WO2004103293A2 Modulators of the p2y10 receptor useful in altering t lymphocyte function
12/02/2004	WO2004103288A2 Method of preventing recurrent miscarriages
12/02/2004	WO2004083363A3 Therapeutical use of anti-myelin associated glycoprotein (mag) antibodies
12/02/2004	WO2004081174A3 Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker
12/02/2004	WO2004078909A8 Identification of antigen epitopes
12/02/2004	WO2004078215A3 Use of antibody conjugated deoxycytidine kinase for adept
12/02/2004	WO2004073653A8 Methods for treating pain by administering a nerve growth factor antagonist and an nsaid and compositions containing the same
12/02/2004	WO2004050834A3 GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER
12/02/2004	WO2004050708A3 Antibody for the thyrotropin receptor and uses thereof
12/02/2004	WO2004049794A3 Single chain antibodies produced in a transgenic mouse
12/02/2004	WO2004042064A3 Disorders of lipid metabolism
12/02/2004	WO2004037198A3 Antibody-mediated induction of tumor cell death
12/02/2004	WO2004031362A3 Multimeric protein engineering
12/02/2004	WO2003085377A3 Novel pancortin-pablo protein interactions and methods of use thereof
12/02/2004	WO2003078465A8 The use of an epitope of vascular endothelial growth factor receptor kdr/flk-1
12/02/2004	WO2003063767A3 Rsv proteins, antibodies, compositions, methods and uses
12/02/2004	WO2003011106A3 Internal image antibodies for optical imaging and therapy
12/02/2004	WO2002068583A3 Enzymes having dehalogenase activity and methods of use thereof
12/02/2004	US20040242860 Compositions and methods for the diagnosis and treatment of tumor
12/02/2004	US20040242851 Immunoglobulin specifiic for vascular endothelial growth factor receptor for use in treatment and prevention of tumor; angiogenesis inhibitors; antitumor agents; antimetastasis agents; immunotherapy
12/02/2004	US20040242849 Using electrophoretic migration, isoelectric focusing and and electrical pulse reversal (pulse field electrophoresis) to separate and recover monoclonal antibodies in solution
12/02/2004	US20040242848 Monoclonal antibodies for treating phencyclidine (PCP) and phencyclidine-like drug abuse; immunoglobulins
12/02/2004	US20040242847 Monoclonal antibody for use as a preventive and/or remedy cancer, inflammation, hormone and blood diseases; immunotherapy
12/02/2004	US20040242517 A nucleic acid construct encoding the antigenic determinant of a mutable pathogen; an isolated cell containing the construct; genetic engineering; vaccination; immunotherapy
12/02/2004	US20040242513 Tub antisense constructs
12/02/2004	US20040242486 for promoting the survival, growth, proliferation, or maintenance of neurons in an injured but not severed spinal cord; promoting axonal regeneration, inhibiting the effects of scar tissue formation; antiapoptotic agents
12/02/2004	US20040242483 Molecules, compositions, methods and kits for applications associated with flaviviruses
12/02/2004	US20040242462 Detecting that individual's Tob gene, transcript and/or protein and comparing with normal Tob gene, transcript and/or protein, differences present indicating that the probability of that individual suffering from amnesia
12/02/2004	US20040241856 Using hematopoietic stem cell inhibition polypeptide to control differentiation of progenitor cells; for use in tissue engineering, bone marrow transplantation and tumor therapeutics
12/02/2004	US20040241853 Introducing one or more mutations into a template double-stranded polynucleotide via hybridization, replication and amplification of random genomic double stranded and heterozygous oligonucleotides sequences; genomics and directed evolution
12/02/2004	US20040241826 Mycobacterial antigens expressed during latency
12/02/2004	US20040241817 Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function
12/02/2004	US20040241808 Methods for ex vivo hybridoma-free production of polyclonal and monoclonal antibodies and generation of immortalized cell populations
12/02/2004	US20040241807 Interleukin-1 related gene and protein
12/02/2004	US20040241805 Cell surface binding protein for use in treatment, diagnosis and prevention of cancer, inflammation, autoimmunity, allergy, asthma and nervous system disorders
12/02/2004	US20040241803 25 human secreted proteins
12/02/2004	US20040241801 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor
12/02/2004	US20040241775 Methods and kits for determining risk of pre-term delivery
12/02/2004	US20040241762 Assessing neuronal damage from blood samples
12/02/2004	US20040241758 CD 30 ligand
12/02/2004	US20040241745 Substance specific to pd-1
12/02/2004	US20040241739 Genes and polynucleotides associated with ultraviolet radiation-mediated skin damage and uses thereof
12/02/2004	US20040241703 Using tumor specific marker to diagnose and treat cell proliferative disorders; immunodiagnostics
12/02/2004	US20040241701 Fusing distinct genetic elements to generate preferential proteins; directed protein evolution
12/02/2004	US20040241694 Using expression patter of neurodegenerative marker to diagnose/prognose brain disorders
12/02/2004	US20040241682 Cancer
12/02/2004	US20040241671 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their us as medicines
12/02/2004	US20040241641 Monoclonal antibody for prevention and treatment of human immunodeficiency viral infection; immunotherapy
12/02/2004	US20040241640 Internalisation of virus into cells
12/02/2004	US20040241639 Human tachykinin-related splice variants and compositions thereof
12/02/2004	US20040241175 Antigen targeting
12/02/2004	US20040241169 Administering antibodies, CD antigens to induce diarrhea, enterocolitis, dermatitis, hypophysitis, panhypopituitarism, rash, pruritis, dermatitis, vitiligo, and enterocolitis; cancer treatment
12/02/2004	US20040241164 Use of antibodies having high affinity for soluble ab to treat conditions and diseases related to ass
12/02/2004	US20040241162 Activation and expansion of cells
12/02/2004	US20040241160 Vegfr-1 antibodies to treat breast cancer
12/02/2004	US20040241102 Methods of using immunoglobulin (Ig) compositions
12/02/2004	US20040241095 Complex containing cyanine dyes; supplying to target tumor cells
12/02/2004	CA2526661A1 Diagnostic kit for liver cirrhosis comprising an antibody specific for human protooncogenic protein
12/02/2004	CA2526403A1 New enterovirus, vaccines, medicaments and diagnostic kits
12/02/2004	CA2525954A1 Ura5 gene and methods for stable genetic integration in yeast
12/02/2004	CA2525840A1 Ovr115 antibody composition and methods of use
12/02/2004	CA2525781A1 Method for the prediction, diagnosis and differential diagnosis of alzheimer's disease
12/02/2004	CA2525181A1 Tnf-like secreted protein
12/02/2004	CA2521490A1 Production of recombinant igm in per.c6 cells
12/01/2004	EP1482309A1 Means for detecting protein conformation and applications thereof
12/01/2004	EP1482052A1 Modified polypeptides for targeting cell-entry of the adenoviruses of subtype B
12/01/2004	EP1482049A2 A protein tyrosine kinase.
12/01/2004	EP1482043A1 Proteins capable of binding to environmental hormones and process for producing the same
12/01/2004	EP1482042A1 Active and inactive CC-chemokine receptors and nucleic acid molecules encoding said receptor
12/01/2004	EP1482041A1 Nnl6 tie receptor tyrosine kinase ligand homologues
12/01/2004	EP1482040A2 NL3 TIE receptor tyrosine kinase ligand homologues
12/01/2004	EP1481993A1 Modulation of the poliovirus receptor function
12/01/2004	EP1481992A2 Humanized antibodies that sequester amyloid beta peptide
12/01/2004	EP1481990A1 A-33 related antigens and their pharmacological uses
12/01/2004	EP1481989A1 A-33 related antigens and their pharmacological uses
12/01/2004	EP1481059A1 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
12/01/2004	EP1481057A1 System and method for the production of recombinant glycosylated proteins in a prokaryotic host
12/01/2004	EP1481011A1 Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins
12/01/2004	EP1481010A2 Anti-interleukin-1 beta analogs
12/01/2004	EP1481008A2 Anti-amyloid beta antibodies and their use
12/01/2004	EP1481007A2 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, treatments and animal models produced therefrom
12/01/2004	EP1481003A2 Hsp70-derived peptides an uses thereof in the diagnosis and treatment of autoimmune diseases
12/01/2004	EP1480997A2 Haemophilus adherence and penetration proteins
12/01/2004	EP1480675A2 Immunoglobulin purification
12/01/2004	EP1480672A2 Compositions and compounds for use as a nicotine vaccine employing response selective agonist of an antigen-presenting cell receptor as a molecular adjuvant
12/01/2004	EP1480666A2 Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein
12/01/2004	EP1480598A2 Manipulation of cytokine levels using cd83 gene products
12/01/2004	EP1480519A1 Re-activated t-cells for adoptive immunotherapy
12/01/2004	EP1351991A4 Ternary biomolecule/polymer/surface-based immobilization systems
12/01/2004	EP1257584B9 Humanized antibodies that sequester amyloid beta peptide
12/01/2004	EP1189631B1 Neurodegenerative disorder related gene
12/01/2004	EP0961838A4 Reading frame independent epitope tagging
12/01/2004	EP0944837B1 Method for determining protein s
12/01/2004	EP0912611B9 Human monoclonal antibodies to the hepatitis b surface antigen
12/01/2004	EP0909320A4 CHEMOKINE beta-15
12/01/2004	EP0845540B1 Monoclonal antibody and antigen relating to human pulmonary adenocarcinoma and immunoassay method with the use of the same
12/01/2004	EP0720650B1 Human metabotropic glutamate receptor subtype hmglur7 and related dna compounds
12/01/2004	CN1551919A 治疗性结合分子 Therapeutic binding molecules
12/01/2004	CN1551886A Specific human antibodies for selective cancer therapy
12/01/2004	CN1551783A Method for treating multiple myeloma

1 ... 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 ... 1494